Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Daily short sale tracking: Amcor's short volume increased by 49 million, with a short sale ratio of 39%
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Super Micro Computer, Snap to Decline
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
Sell Rating Maintained for Hims & Hers Health Amid Market Concerns Despite Strategic Partnership With Novo Nordisk
Earnings Preview: HIMS to Report Financial Results Post-market on May 05
Top Gap Ups and Downs on Tuesday: HON, SPOT, BBVA and More
U.S. stocks closed: the S&P 500 Index has risen for six consecutive days as investors anticipate Trump to adjust the tariff policy.
① Amazon was forced to terminate the plan to display the impact of tariffs on commodity pages; ② China Concept Stocks fluctuated, and the Nasdaq China Golden Dragon Index fell by 0.3%; ③ Meta released an independent AI application aiming to create a personalized Asia Vets assistant; ④ Starbucks reported a Q2 revenue of 8.8 billion dollars, below market expectations.
Hims & Hers Health Options Spot-On: On April 29th, 448K Contracts Were Traded, With 555.97K Open Interest
U.S. Small Caps Close Up; Hims & Hers Health Leads Increases
US Equities Markets End Higher Tuesday Despite Soft Economic Data
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
TD Cowen Downgrades Hims & Hers Health(HIMS.US) to Hold Rating, Raises Target Price to $30
Citi Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $25
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $40
Express News | B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $26
Top Midday Stories: Amazon Says Listing Tariff Pricing Never Considered for Main Site; Novo Nordisk Partners With Hims on Wegovy
SA Analyst Upgrades: TSLA, PYPL, QBTS, ANET, HIMS, NYT
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday
U.S. stocks are moving | Hims & Hers Health (HIMS.US) rises over 21% after reaching a cooperation agreement with Novo-Nordisk A/S (NVO.US).
As of the time of writing, the stock has risen over 21%, trading at $34.81.